SilcsBio, Helix BioStructures Launch Partnership to Collaborate in Pharmaceutical Drug Design Opportunities
SilcsBio, an Early Charm drug design portfolio company, today announced the launch of a partnership with Helix BioStructures to tap mutual areas of expertise in drug design and spur new opportunities for pharmaceutical and research organizations.
